Conatus Pharmaceuticals Inc. (CNAT) surged 6.51% or 0.06 to $0.92. It is near 189573 shares traded, which is 16.78% compare to the average total volume 1.13 million. The market cap of CNAT is $30.45 million. The year to date change is -45.87%. The 52 week price range is from $0.69 to $6.74. Price of CNAT have changed 3.84% during last week. It have changed -33.70% over last month, -56.90% over last 3 months, -83.65% over last 6 months and -76.89% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CNAT is 1.51. It is 64.13% above current price. The 200-day Moving Averages for CNAT is 3.14. It is 241.30% above current price. The 52-week High is 6.74. It is 632.61% from the current price. The 52-week Low is 0.69. It is -25.00% from current price.
There are some statistics of CNAT. It is has market cap $30.45 million. The share outstanding is 33.17 million. The average volume is 1.13 million. The percent of top 15 Institution holding is 34.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CNAT is -79.07%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CNAT is -31.68%.